AQ-13

DRUG2 trials

Sponsors

Tulane University Health Sciences Center

Conditions

Malaria

Phase 1

Studies of AQ-13, a Candidate Aminoquinoline Antimalarial, in Comparison With Chloroquine

CompletedNCT00323375

Tulane University Health Sciences CenterMalaria

Start: 1999-08-01End: 2005-08-31Updated: 2020-12-08

Food-Effect Bioavailability Study of AQ-13, a Candidate Antimalarial

CompletedNCT00455494

Tulane University Health Sciences CenterMalaria

Start: 2005-01-31End: 2006-12-31Target: 14Updated: 2020-12-07